Consolidated Statements of Cash Flows - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net income		$ 5,942	$ 6,341
Adjustments to reconcile net income to net cash provided by operating activities:
Provisions for credit losses		1,155	(1,472)
Depreciation and amortization		1,208	1,276
Stock-based compensation		282	256
Deferred taxes		(749)	153
Other non-cash items	[1]	535	(599)
Originations of loans held-for-sale		(185)	0
Proceeds from sales of loans held-for-sale		180	0
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:
Other assets		409	863
Accounts payable & other liabilities		3,870	2,819
Net cash provided by operating activities		12,647	9,637
Cash Flows from Investing Activities
Sale of investment securities		25	37
Maturities and redemptions of investment securities		1,738	12,803
Purchase of investments		(3,890)	(1,179)
Net increase in Card Member loans and receivables, and other loans		(19,431)	(9,790)
Purchase of premises and equipment, net of sales: 2022, $1; 2021, $41		(1,342)	(1,079)
Acquisitions/dispositions, net of cash acquired		(15)	1
Net cash (used in) provided by investing activities		(22,915)	793
Cash Flows from Financing Activities
Net increase (decrease) in customer deposits		19,148	(2,534)
Net (decrease) increase in short-term borrowings		(438)	428
Proceeds from long-term debt		20,740	38
Payments of long-term debt		(16,549)	(8,247)
Issuance of American Express preferred shares		0	1,584
Redemption of American Express preferred shares		0	(850)
Issuance of American Express common shares		54	54
Repurchase of American Express common shares and other		(2,862)	(4,681)
Dividends paid		(1,160)	(1,090)
Net cash provided by (used in) financing activities		18,933	(15,298)
Effect of foreign currency exchange rates on cash and cash equivalents		489	(181)
Net increase (decrease) in cash and cash equivalents		9,154	(5,049)
Cash and cash equivalents at beginning of period		22,028	32,965
Cash and cash equivalents at end of period		$ 31,182	$ 27,916

[1] Includes net gains and losses on fair value hedges, changes in equity method investments and net gains and losses on Amex Ventures investments.